FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 107 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -28.6% | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | -41.7% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $12,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $9,000 | -18.2% | 300 | 0.0% | 0.00% | – |
| Q1 2017 | $11,000 | -26.7% | 300 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | -6.2% | 300 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | +33.3% | 300 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2016 | $12,000 | -42.9% | 300 | -40.0% | 0.00% | – |
| Q4 2015 | $21,000 | +162.5% | 500 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q2 2015 | $12,000 | +9.1% | 500 | 0.0% | 0.00% | – |
| Q1 2015 | $11,000 | -21.4% | 500 | 0.0% | 0.00% | – |
| Q4 2014 | $14,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|